Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A study

Cancer Treat Rep. 1983 Sep;67(9):845-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aminoacridines / therapeutic use*
  • Amsacrine
  • Carcinoma, Transitional Cell / drug therapy*
  • Drug Evaluation
  • Epithelium
  • Humans
  • Kidney Neoplasms / drug therapy
  • Neoplasm Metastasis
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Aminoacridines
  • Amsacrine